Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 110 shares at $34.62 ($4K) on 2021-01-22, disclosed to the SEC on 2021-01-25.
Scheduled sale ($4k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALBO | SELL | 2022-10-25 | $13K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $16K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $22K | — | Filing → |